MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT

INTRODUCTION: Lupus nephritis (LN) is more prevalent in patients with SLE of Asian ethnicity than in Caucasian patients. Belimumab became available in Japan in 2017 to treat patients with SLE, including those with LN. In the BLISS-LN trial (NCT01639339), belimumab showed a favourable effect on renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Sada, Kenei, Kurita, Noriaki, Noma, Hisashi, Matsuki, Taizo, Quasny, Holly, Levy, Roger A, Jones-Leone, Angela R, Gairy, Kerry, Yajima, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Lupus Nephritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438087/
https://www.ncbi.nlm.nih.gov/pubmed/37017254
http://dx.doi.org/10.1136/lupus-2022-000746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438087/
https://www.ncbi.nlm.nih.gov/pubmed/37017254
http://dx.doi.org/10.1136/lupus-2022-000746

Ejemplares similares